You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Reversal of Myocardial Infarction by Localized Stimulation

    SBC: Micro Vide, LLC            Topic: NHLBI

    DESCRIPTION provided by applicant Heart attacks i e myocardial infarction or MI occur in more than million patients annually Advances in pharmacological therapy have dramatically improved survival following the initial MI Consequently the number of patients with previous MI continues to increase and as a result put in jeopardy millions of patients for development of heart failure I ...

    STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  2. Commercialization of a Diagnostic test for amyotrophic lateral sclerosis (ALS)

    SBC: IRON HORSE DIAGNOSTICS, INC.            Topic: 101

    DESCRIPTION provided by applicant Amyotrophic lateral sclerosis ALS or Lou Gehrigandapos s disease is a fatal neurodegenerative disease with a typical lifespan of years after diagnosis The initial symptoms can be similar to many other neurologic disorders and often begin with limb weakness muscle fasciculations or increasing difficulties in speech or breathing No definitive diagnost ...

    STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  3. Patch Clamp Amplifiers on a Chip

    SBC: HARVARD BIOSCIENCE, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The patch-clamp technique is the central tool for characterizing ion channel function. For functional genomics and for drug discovery, the ability to perform high-throughput (HTS) patch clamp recordings is urgently needed. We propose to develop an enabling technology for HTS recordings by integrating a high-performance patch-clamp amplifier into a single monoli ...

    STTR Phase II 2009 Department of Health and Human ServicesNational Institutes of Health
  4. High-resolution Smart Optical Probe for Breast Biopsy Guidance

    SBC: PHYSICAL SCIENCES INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Fine needle aspiration biopsy (FNAB) is a rapid and cost-effective procedure that uses a syringe to sample fluid from a cyst or remove clusters of cells from a solid mass for diagnostic purposes. The effectiveness of FNAB is operator-dependent and the diagnostic yield could be low, especially for adipose- rich tissue and masses where the percentage of non-diagn ...

    STTR Phase II 2009 Department of Health and Human ServicesNational Institutes of Health
  5. Behavioral Intervention in Autism: Practitioner Skills

    SBC: PRAXIS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Autism Spectrum Disorder (ASD) is a complex neurological disorder that typically appears before the age of three and immediately and profoundly affects a young child's ability to communicate, develop language, form social relationships and respond appropriately to environmental cues. Whereas all children with developmental disabilities receive some form of fede ...

    STTR Phase II 2009 Department of Health and Human ServicesNational Institutes of Health
  6. VISION: Volumetric Imaging for Science Instruction of an Open Nature

    SBC: SCIENCE-APPROACH            Topic: N/A

    DESCRIPTION (provided by applicant): The goal of this Phase II Small Business Technology Transfer (STTR) application-entitled Volumetric Imaging for Science Instruction of an Open Nature (VISION)-is to adapt an advanced technology employed in biomedical research and practice-volumetric image processing and analysis (VIPA)-for science and mathematics education in formal secondary school settings. ...

    STTR Phase II 2009 Department of Health and Human ServicesNational Institutes of Health
  7. Experimental Pharmacology and Chemical Studies of Nikkomycin Z

    SBC: VALLEY FEVER THERAPIES LLC            Topic: N/A

    Not Available

    STTR Phase II 2009 Department of Health and Human ServicesNational Institutes of Health
  8. TILLING wheat for reduced celiac disease causing proteins

    SBC: Arcadia Biosciences, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): Celiac disease is an autoimmune digestive disorder in which intestinal lesions develop in genetically susceptible individuals in response to the ingestion of specific cereal seed storage proteins. The only treatment is strict adherence to a diet free from the offending grains. Therefore, considerable research has been devoted to identifying the specific amino a ...

    STTR Phase II 2009 Department of Health and Human ServicesNational Institutes of Health
  9. Restoration of Skin Structure and Function Post-Wounding

    SBC: FirstString Research, Inc            Topic: N/A

    DESCRIPTION (provided by applicant): The wound repair process in skin is initiated immediately after an injury and induces a cascade of events including inflammation, proliferation, and scar differentiation. The adverse changes in skin structure and function resulting from scar tissue affects over 35 million US citizens a year resulting in costs of more than 7 billion dollars). The founders of Fir ...

    STTR Phase II 2009 Department of Health and Human ServicesNational Institutes of Health
  10. DNA HELICASE AND PRIMASE INHIBITORS FOR BIODEFENSE

    SBC: MICROBIOTIX, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The increasing prevalence of antibiotic-resistant strains of bacterial pathogens represents a major unmet medical need. Naturally occuring or intentionally engineered drug-resistance in biothreat agents is also a serious risk for biodefense. The development of new antibiotics against unexploited targets with novel mechanisms of action is a vital part of the sol ...

    STTR Phase II 2009 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government